Agios Pharm Stock Price on September 30, 2023
| AGIO Stock | USD 55.54 0.92 1.68% |
Below is the normalized historical share price chart for Agios Pharm extending back to July 24, 2013. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Agios Pharm stands at 55.54, as last reported on the 22nd of November, with the highest price reaching 56.27 and the lowest price hitting 53.93 during the day.
If you're considering investing in Agios Stock, it is important to understand the factors that can impact its price. Agios Pharm appears to be very steady, given 3 months investment horizon. Agios Pharm secures Sharpe Ratio (or Efficiency) of 0.11, which signifies that the company had a 0.11% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Agios Pharm, which you can use to evaluate the volatility of the firm. Please makes use of Agios Pharm's Downside Deviation of 2.67, risk adjusted performance of 0.0831, and Mean Deviation of 2.25 to double-check if our risk estimates are consistent with your expectations.
At this time, Agios Pharm's Capital Stock is very stable compared to the past year. As of the 22nd of November 2024, Stock Based Compensation To Revenue is likely to grow to 1.75, while Total Stockholder Equity is likely to drop about 564.7 M. . As of the 22nd of November 2024, Price To Sales Ratio is likely to drop to 32.17. In addition to that, Price Earnings Ratio is likely to drop to -3.7. Agios Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 24th of July 2013 | 200 Day MA 39.9562 | 50 Day MA 47.028 | Beta 0.751 |
Agios |
Sharpe Ratio = 0.1074
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | AGIO | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 2.96 actual daily | 26 74% of assets are more volatile |
Expected Return
| 0.32 actual daily | 6 94% of assets have higher returns |
Risk-Adjusted Return
| 0.11 actual daily | 8 92% of assets perform better |
Based on monthly moving average Agios Pharm is performing at about 8% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Agios Pharm by adding it to a well-diversified portfolio.
Price Book 1.9472 | Enterprise Value Ebitda (2.33) | Price Sales 96.3602 | Shares Float 50.5 M | Wall Street Target Price 53.875 |
Agios Pharm Valuation on September 30, 2023
It is possible to determine the worth of Agios Pharm on a given historical date. On September 30, 2023 Agios was worth 24.97 at the beginning of the trading date compared to the closed value of 24.75. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Agios Pharm stock. Still, in general, we apply an absolute valuation method to find Agios Pharm's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Agios Pharm where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Agios Pharm's related companies.
| Open | High | Low | Close | Volume | |
| 24.43 | 24.79 | 24.04 | 24.77 | 212,800 | |
09/29/2023 | 24.97 | 25.21 | 24.50 | 24.75 | 439,064 |
| 24.74 | 24.74 | 23.84 | 24.22 | 327,040 |
| Backtest Agios Pharm | | | Agios Pharm History | | | Agios Pharm Valuation | Previous | Next |
Agios Pharm Trading Date Momentum on September 30, 2023
| On October 02 2023 Agios Pharm was traded for 24.22 at the closing time. The top price for the day was 24.74 and the lowest listed price was 23.84 . The trading volume for the day was 327 K. The trading history from October 2, 2023 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 2.14% . The overall trading delta against the current closing price is 3.80% . |
Agios Pharm Fundamentals Correlations and Trends
By evaluating Agios Pharm's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Agios Pharm's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Agios financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Agios Pharm Stock history
Agios Pharm investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Agios is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Agios Pharm will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Agios Pharm stock prices may prove useful in developing a viable investing in Agios Pharm
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 55.7 M | 48.8 M | |
| Net Loss | -266.6 M | -253.2 M |
Agios Pharm Quarterly Net Working Capital |
|
Agios Pharm Stock Technical Analysis
Agios Pharm technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Agios Pharm Period Price Range
Low | November 22, 2024
| High |
0.00 | 0.00 |
Agios Pharm cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Agios Pharm November 22, 2024 Market Strength
Market strength indicators help investors to evaluate how Agios Pharm stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Agios Pharm shares will generate the highest return on investment. By undertsting and applying Agios Pharm stock market strength indicators, traders can identify Agios Pharm entry and exit signals to maximize returns
Agios Pharm Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Agios Pharm's price direction in advance. Along with the technical and fundamental analysis of Agios Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Agios to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0831 | |||
| Jensen Alpha | 0.0637 | |||
| Total Risk Alpha | (0.10) | |||
| Sortino Ratio | 0.0684 | |||
| Treynor Ratio | 0.1285 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Agios Pharm. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. To learn how to invest in Agios Stock, please use our How to Invest in Agios Pharm guide.You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Agios Pharm. If investors know Agios will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Agios Pharm listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 11.66 | Revenue Per Share 0.582 | Quarterly Revenue Growth 0.212 | Return On Assets (0.18) | Return On Equity 0.5366 |
The market value of Agios Pharm is measured differently than its book value, which is the value of Agios that is recorded on the company's balance sheet. Investors also form their own opinion of Agios Pharm's value that differs from its market value or its book value, called intrinsic value, which is Agios Pharm's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Agios Pharm's market value can be influenced by many factors that don't directly affect Agios Pharm's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Agios Pharm's value and its price as these two are different measures arrived at by different means. Investors typically determine if Agios Pharm is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Agios Pharm's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.